Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Impact of Maximum Plasma Concentration of Busulfan in Pediatric Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation.

Clinical pharmacology and therapeutics·2026
Same author

Population Pharmacokinetics of Melphalan in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation with Various Conditioning Regimens.

European journal of drug metabolism and pharmacokinetics·2026
Same author

Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome.

Annals of hematology·2025
Same author

Shear wave elastography and dispersion imaging for hepatic veno-occlusive disease prediction after pediatric hematopoietic stem cell transplantation: a feasibility study.

Pediatric radiology·2024
Same author

Hemophagocytic lymphohistiocytosis associated with parvovirus B19-induced aplastic crisis in a hereditary spherocytosis patient: A case report and literature review.

Pediatric hematology and oncology·2021
Same author

Erratum: Correction of Affiliations in the Article "Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study".

Journal of Korean medical science·2021

Related Experiment Video

Updated: Aug 10, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.3K

Medulloblastoma: Current Perspectives and Recent Advances.

Jung Yoon Choi1

  • 1Department of Pediatrics, Seoul National University College of Medicine, Seoul National University Cancer Research Institute, Seoul, Korea. choijy@snu.ac.kr.

Brain Tumor Research and Treatment
|February 10, 2023
PubMed
Summary

Childhood medulloblastoma treatment is improving with combined therapies. Integrated genomics offers new biology-based risk stratification, aiming for better survival with fewer side effects.

Keywords:
Antineoplastic protocolsClinical trialMedulloblastomaMolecular subgroupPediatrics

More Related Videos

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.0K

Related Experiment Videos

Last Updated: Aug 10, 2025

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.3K
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.4K
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
10:58

Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma

Published on: February 22, 2015

13.0K

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Genomics

Background:

  • Medulloblastoma is the most common pediatric central nervous system embryonal tumor.
  • Current treatments combine surgery, radiation, and chemotherapy, improving outcomes.
  • Genomic research reveals medulloblastoma is not a single entity, necessitating refined risk assessment.

Purpose of the Study:

  • To highlight the need for integrating genetic findings into medulloblastoma care.
  • To emphasize the development of new biology-based risk stratification methods.
  • To underscore the importance of understanding genetic predisposition in patients.

Main Methods:

  • Review of advances in genomic research for medulloblastoma.
  • Analysis of traditional risk stratification factors (histology, metastasis, resection, age).
  • Exploration of integrated genomics for novel risk stratification.

Main Results:

  • Medulloblastoma heterogeneity is increasingly understood through genomics.
  • New biology-based risk stratification methods are emerging.
  • Genetic predisposition plays a crucial role in patient outcomes.

Conclusions:

  • Treatment goals focus on improving survival while minimizing adverse effects and long-term sequelae.
  • Incorporating genetic findings into the standard of care is essential.
  • Clinical trials must be designed to reflect these genetic insights.